These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35853675)

  • 21. The role of ixekizumab in non-radiographic axial spondyloarthritis.
    San Koo B; Kim TH
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X20986734. PubMed ID: 33488787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacy and safety of bimekizumab in axial spondyloarthritis: a systematic literature review and network meta-analysis.
    Deodhar A; Machado PM; Mørup M; Taieb V; Willems D; Orme M; Pritchett D; Gensler LS
    Rheumatology (Oxford); 2024 May; 63(5):1195-1205. PubMed ID: 37947318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost-effectiveness of a bimekizumab versus IL-17A inhibitors treatment-pathway in patients with active axial spondyloarthritis in Scotland.
    Mørup MF; Taieb V; Willems D; Rose M; Lyris N; Lamotte M; Gerlier L; Thom H
    J Med Econ; 2024; 27(1):682-696. PubMed ID: 38650583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study.
    Landewé RBM; Poddubnyy D; Rahman P; Van den Bosch FE; Bolce R; Liu Leage S; Lisse JR; Park SY; Gensler L
    Ann Rheum Dis; 2023 Feb; 82(2):212-216. PubMed ID: 36100350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ixekizumab in radiographic axial spondyloarthritis with and without elevated C-reactive protein or positive magnetic resonance imaging.
    Maksymowych WP; Bolce R; Gallo G; Seem E; Geneus VJ; Sandoval DM; Østergaard M; Tada K; Baraliakos X; Deodhar A; Gensler LS
    Rheumatology (Oxford); 2022 Nov; 61(11):4324-4334. PubMed ID: 35188180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial.
    Deodhar A; Mease P; Rahman P; Navarro-Compán V; Marzo-Ortega H; Hunter T; Sandoval D; Kronbergs A; Leon L; Shan M; Leung A; De Vlam K; Strand V
    Rheumatol Ther; 2021 Mar; 8(1):135-150. PubMed ID: 33284423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study.
    Christiansen SN; Horskjær Rasmussen S; Ostergaard M; Pons M; Michelsen B; Pavelka K; Codreanu C; Ciurea A; Glintborg B; Santos MJ; Sari I; Rotar Z; Gudbjornsson B; Macfarlane GJ; Relas H; Iannone F; Laas K; Wallman JK; van de Sande M; Provan SA; Castrejon I; Zavada J; Mogosan C; Nissen MJ; Loft AG; Barcelos A; Erez Y; Pirkmajer KP; Grondal G; Jones GT; Hokkanen AM; Chimenti MS; Vorobjov S; Di Giuseppe D; Kvien TK; Otero-Varela L; van der Horst-Bruinsma I; Hetland ML; Ørnbjerg LM
    RMD Open; 2024 Jul; 10(3):. PubMed ID: 39053949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similar biologic drug response regardless of radiographic status in axial spondyloarthritis: data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registry.
    Michelena X; Zhao SS; Dubash S; Dean LE; Jones GT; Marzo-Ortega H
    Rheumatology (Oxford); 2021 Dec; 60(12):5795-5800. PubMed ID: 33502476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
    Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
    Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).
    Sieper J; van der Heijde D; Dougados M; Mease PJ; Maksymowych WP; Brown MA; Arora V; Pangan AL
    Ann Rheum Dis; 2013 Jun; 72(6):815-22. PubMed ID: 22772328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trial.
    Sieper J; Landewé R; Rudwaleit M; van der Heijde D; Dougados M; Mease PJ; Braun J; Deodhar A; Kivitz A; Walsh J; Hoepken B; Nurminen T; Maksymowych WP
    Arthritis Rheumatol; 2015 Mar; 67(3):668-77. PubMed ID: 25470228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis.
    Maksymowych WP; Thom H; Mørup MF; Taieb V; Willems D; Lyris N; Gaffney K
    Rheumatol Ther; 2024 Aug; 11(4):1023-1041. PubMed ID: 38916823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study.
    Baraliakos X; van der Heijde D; Sieper J; Inman RD; Kameda H; Li Y; Bu X; Shmagel A; Wung P; Song IH; Deodhar A
    Arthritis Res Ther; 2023 Sep; 25(1):172. PubMed ID: 37723577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis.
    Ramonda R; Lorenzin M; Chimenti MS; D'Angelo S; Marchesoni A; Selmi C; Lubrano E; Santo L; Luchetti Gentiloni MM; Atzeni F; Cauli A; Manara M; Rossini M; Foti R; Cozzi G; Scagnellato L; Ferraioli M; Carriero A; Luciano N; Ruzzon F; Fatica M; Fracassi E; Doria A; Foti R; Carletto A
    Front Immunol; 2024; 15():1435599. PubMed ID: 39076975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trial.
    Proft F; Weiß A; Torgutalp M; Protopopov M; Rodriguez VR; Haibel H; Behmer O; Sieper J; Poddubnyy D
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X20987700. PubMed ID: 33796155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol.
    Maksymowych WP; Kumke T; Auteri SE; Hoepken B; Bauer L; Rudwaleit M
    Arthritis Res Ther; 2021 Oct; 23(1):274. PubMed ID: 34715908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ixekizumab improves sleep and work productivity in patients with non-radiographic axial spondyloarthritis: results from the COAST-X trial at 52 weeks.
    Deodhar A; Mease P; Marzo-Ortega H; Hunter T; Sandoval D; Kronbergs A; Lauzon S; Leung A; Navarro-Compán V
    BMC Rheumatol; 2021 Sep; 5(1):50. PubMed ID: 34560906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy and safety of ixekizumab: A 5-year analysis of the UNCOVER-3 randomized controlled trial.
    Blauvelt A; Lebwohl MG; Mabuchi T; Leung A; Garrelts A; Crane H; ElMaraghy H; Patel H; Ridenour T; See K; Gallo G; Paul C
    J Am Acad Dermatol; 2021 Aug; 85(2):360-368. PubMed ID: 33253833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term tolerability and efficacy of golimumab in active non-radiographic axial spondyloarthritis: results from open-label extension.
    van der Heijde D; Dougados M; Maksymowych WP; Bergman G; Curtis SP; Tzontcheva A; Huyck S; Philip G; Sieper J
    Rheumatology (Oxford); 2022 Feb; 61(2):617-627. PubMed ID: 33878154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
    Malaviya AN; Kalyani A; Rawat R; Gogia SB
    Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.